Recent Cases
25 August 2010 - Novartis AG completes acquisition of 52% stake in Alcon Inc. for USD 28.3 billion
On 25 August 2010, Novartis AG has completed the purchase of 52 percent of the shares in Alcon Inc. from Nestlé SA for a consideration of USD 28.3 billion, exercising its call option provided for in the agreement, concluded between Novartis AG and Nestlé in April 2008. With the acquisition of the additional stake, Novartis AG now holds a total of 77 percent of the shares in Alcon Inc.
Bär & Karrer acted as Swiss legal adviser to Novartis AG. The team included Rolf Watter, Charlotte Wieser, Urs Kägi and Georg Frey (all M&A/corporate). Allen & Overy New York advised Novartis AG as to US and international competition law.